Stocks
Champions Oncology, Inc.CSBR
NASDAQHealthcareBiotechnology$4.85
Price as of · delayed, not real-time
A provider of tumor response data and related services for oncology drug development, operating a laboratory that tests patient-derived xenografts in mice. The company generates revenue from biopharmaceutical clients and academic researchers seeking preclinical efficacy data. Investors track it as a small-cap play on the growth of precision medicine and the outsourcing of oncology research.
52W Range: $4.59-$8.31
Congressional Interest in Champions Oncology, Inc. (CSBR)
No congressional trades have been disclosed for Champions Oncology, Inc. (CSBR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CSBR?
No congressional trades found for this stock.